Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 35
  • Start Date: January 31, 2021
A Post Marketing Surveillance (PMS) Study for VPRIV (Velaglucerase Alfa) in India
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 140
  • Start Date: September 30, 2020
Complement Activation in the Lysosomal Storage Disorders
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 15
  • Start Date: September 2020
An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose PR001A in Infants With Type 2 Gaucher Disease
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 12
  • Start Date: January 3, 2020
A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of PR001A in Patients With Parkinson's Disease With at Least One GBA1 Mutation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 15
  • Start Date: November 20, 2019
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
Showing 1-12 of 38